The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Oncology
- Gastrointestinal
- Pulmonary
- Neurology
- Hematology
- Cardio-vascular
- Metabolic disorders
- Endocrinology
- Infectious diseases
- Others
Segment by Application
- Hospital Pharmacies
- Speciality Pharmacies
- Retail pharmacies
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
By Company
- Novartis AG
- Bristol-Myers Squibb Company
- Celgene Corporation
- F. Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Sanofi S.A.
- Alexion Pharmaceuticals, Inc.
- Eli Lilly and Company
- Novo Nordisk A/S
- AstraZeneca
- Eisai Co., Ltd.
- Daiichi Sankyo Company Limited
- Bayer AG
- GlaxoSmithKline
- Merck & Co., Inc.
- Johnson & Johnson
- Biogen, Inc.
- Takeda
- Amgen, Inc.
Table of content
1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Orphan Drugs Segment by Type
1.2.1 Global Orphan Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oncology
1.2.3 Gastrointestinal
1.2.4 Pulmonary
1.2.5 Neurology
1.2.6 Hematology
1.2.7 Cardio-vascular
1.2.8 Metabolic disorders
1.2.9 Endocrinology
1.2.10 Infectious diseases
1.2.11 Others
1.3 Orphan Drugs Segment by Application
1.3.1 Orphan Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Orphan Drugs Market Size Estimates and Forecasts
1.4.1 Global Orphan Drugs Revenue 2016-2027
1.4.2 Global Orphan Drugs Sales 2016-2027
1.4.3 Orphan Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Orphan Drugs Market Competition by Manufacturers
2.1 Global Orphan Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Orphan Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Orphan Drugs Manufacturing Sites, Area Served, Product Type
2.5 Orphan Drugs Market Competitive Situation and Trends
2.5.1 Orphan Drugs Market Concentration Rate
2.5.2 The Global Top 5 an
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
According to IMARC Group’s latest report, titled “Orphan Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global orphan drugs market reached a value of US$ 174.7 Billion in 2020.
Looking forward, IMARC Group expects the market to grow at a CAGR of 9.8% during 2021-2026.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic.
These observations will be integrated into the report.Request for a free sample copy of this report: https://www.imarcgroup.com/orphan-drugs-market/requestsampleOrphan drugs refer to medications that are intended for diagnosing, preventing and treating rare, life-threatening diseases or disorders.
As they traditionally had a limited market, very few pharmaceutical companies pursued research into these products.
However, the growing number of rare diseases lacking treatment, along with improving access to healthcare and spending capacity of individuals, has led to a significant rise in the demand for orphan drugs.Market Trends and Drivers:At present, incentives for drug development provided by government authorities in various countries are encouraging pharmaceutical companies to develop orphan drugs.
For instance, the United States Food and Drug Administration (USFDA) offers benefits such as fast-track approval, protocol assistance, waiver of fees and marketing exclusivity to manufacturers, facilitating the development and commercialization of diagnostic tools and treatments devoted to rare diseases.
“The overall global orphan drugs market is expected to grow at a significant compound CAGR rate of 11.14% from USD 145.44 billion in 2018 to USD 338.51 billion in 2026".
With the massive development in the field of drug development many key players came into existence.The Orphan Drugs Market consists of many experts with lots of experience in manufacturing drugs.
It is estimated that small and medium-sized markets would depend on incentives provided by the government to survive.
The new comers are estimated to start from the basics by manufacturing drugs and then after upgrading to more complex drugs.Global Orphan Drugs Market: Competitive LandscapeThe key players in the Global Market for orphan drugs include Celgene Corporation, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Alexion Pharmaceuticals Inc, and Johnson & Johnson.
It is estimated that Asian Pacific region is growing rapidly in Healthcare Infrastructure and Research and Development.
Approval of multiple indication for biological orphan drugs has resulted in growth and also encouraging new market entrants in orphan drug market.Global Orphan Drugs Market: Growth DriversEscalation in demand for orphan drugs.Increase in recognition of the disease and drugs among patients and physicians.Rise in the growth of investment in research and development, economic, legislative, and tax benefits provided by governmentsGlobal Orphan Drugs Market: RestraintsOne of the major factors is high cost for development of drugs, which is estimated to be the growth of the overall orphan drugs market in following years.Factors hampering the market are a high treatment cost of diseases, availability of small patient pool for clinical trials & marketing.Threats like competition from generics and biosimilars, costlier clinical trials and extensive post market surveillance, monopolized and unitary market that are to be managed.Hindered commercialization and distributionGlobal Orphan Drugs Market: OpportunitiesSpecific Skills and Knowledge is required to market a rare disease drug which is different for a mass-market product.In Future, increase in novel indications for known orphan drugs and increasing untapped economies account for new market opportunities for orphan drug manufacturers.Regulatory edges like longer market exclusively, reduced fees, and tax incentives.Orphan Drugs Market Based on Disease Type (US$ Mn)Neurologic diseasesInfectious diseasesOncologic diseasesHematologic & immunologic diseasesOrphan Drugs Market Based on Indication (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)Non-Hodgkin LymphomaCystic FibrosisGliomaDuchenne Muscular DystrophyGraft vs.
The latest trending report Global Orphan Drugs Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Orphan Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.3% in the forecast period of 2020 to 2025 and will expected to reach USD 167980 million by 2025, from USD 117860 million in 2019.The Orphan Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/32391-orphan-drugs-market-analysis-reportThe major players covered in Orphan Drugs are: Novartis AG Eli Lilly and Company F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company Alexion Pharmaceuticals, Inc. Celgene Corporation AstraZeneca Sanofi S.A. Pfizer, Inc. Novo Nordisk A/S Merck & Co., Inc. Takeda Eisai Co., Ltd. Johnson & Johnson GlaxoSmithKline Daiichi Sankyo Company Limited Amgen, Inc. Biogen, Inc. Bayer AGBy Type, Orphan Drugs market has been segmented into Oncology Gastrointestinal Pulmonary Neurology Hematology Cardio-vascular Metabolic disorders Endocrinology Infectious diseases OthersBy Application, Orphan Drugs has been segmented into: Hospital Pharmacies Speciality Pharmacies Retail pharmacies OthersThe report offers in-depth assessment of the growth and other aspects of the Orphan Drugs market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, etc.
) Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Orphan Drugs Market @ https://www.decisiondatabases.com/contact/download-sample-32391The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Orphan Drugs product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Orphan Drugs, with price, sales, revenue and global market share of Orphan Drugs in 2018 and 2019.Chapter 3, the Orphan Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Orphan Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Orphan Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Orphan Drugs Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-32391All Drugs Related Reports by DecisionDatabases.com @ https://goo.gl/knWRNbAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
The Global PVC Window Profile Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on type and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global PVC Window Profile Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/53045-pvc-window-profile-market-reportThe report also covers the complete competitive landscape of the global PVC Window Profile market with company profiles of key players such as:Alphacan SpAAluplast GmbHDeceuninckEpwin GroupEurocellPiva GroupProfine GroupRehauSalamanderSchucoVEKASEGMENTATIONS IN THE REPORT:By TypeTurn & Tilt WindowsSliding WindowCasement WindowOthersBy ApplicationResidentialCommercialBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global PVC Window Profile Market @ https://www.decisiondatabases.com/contact/download-sample-53045The Global PVC Window Profile Market has been exhibited in detail in the following chapters –Chapter 1 PVC Window Profile Market PrefaceChapter 2 Executive SummaryChapter 3 PVC Window Profile Industry AnalysisChapter 4 PVC Window Profile Market Value Chain AnalysisChapter 5 PVC Window Profile Market Analysis By TypeChapter 6 PVC Window Profile Market Analysis By ApplicationChapter 7 PVC Window Profile Market Analysis By GeographyChapter 8 Competitive Landscape Of PVC Window Profile CompaniesChapter 9 Company Profiles Of PVC Window Profile IndustryPurchase the complete Global PVC Window Profile Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-53045Other Reports by DecisionDatabases.com:Global PVC Modifier Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Polyvinyl Chloride (PVC) Resins Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Polyvinyl Chloride (PVC) Films Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
The Global Polyvinyl Alcohol Fibers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product type and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Polyvinyl Alcohol Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/52885-polyvinyl-alcohol-fibers-market-reportThe report also covers the complete competitive landscape of the global Polyvinyl Alcohol Fibers market with company profiles of key players such as:Anhui Wanwei Group Co., Ltd.E.
I. du Pont de Nemours and CompanyEastman Chemical CompanyKuraray Co. Ltd.Nippon Synthetic Chemical Industry Co.Sekisui Chemical Co. Ltd.Sinopec Sichuan VinylonSEGMENTATIONS IN THE REPORT:By Product TypeFilament FiberStapleOtherBy ApplicationCement AdditivesTextileNon-Woven FabricBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global Polyvinyl Alcohol Fibers Market @ https://www.decisiondatabases.com/contact/download-sample-52885The Global Polyvinyl Alcohol Fibers Market has been exhibited in detail in the following chapters –Chapter 1 Polyvinyl Alcohol Fibers Market PrefaceChapter 2 Executive SummaryChapter 3 Polyvinyl Alcohol Fibers Industry AnalysisChapter 4 Polyvinyl Alcohol Fibers Market Value Chain AnalysisChapter 5 Polyvinyl Alcohol Fibers Market Analysis By Product TypeChapter 6 Polyvinyl Alcohol Fibers Market Analysis By ApplicationChapter 7 Polyvinyl Alcohol Fibers Market Analysis By GeographyChapter 8 Competitive Landscape Of Polyvinyl Alcohol Fibers CompaniesChapter 9 Company Profiles Of Polyvinyl Alcohol Fibers IndustryPurchase the complete Global Polyvinyl Alcohol Fibers Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-52885Other Reports by DecisionDatabases.com:Global Nanofibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Glass Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Optical Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
According to a research report "Cognitive Assessment and Training Market by Assessment Type (Pen- and Paper-Based, Hosted, Biometrics), Component, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), Vertical, and Region - Global Forecast to 2021", published by MarketsandMarkets, the cognitive assessment and training market size is expected to grow from USD 1.98 Billion in 2016 to USD 8.06 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.3%.Browse 63 market data tables and 47 figures spread through 150 pages and in-depth TOC on "Cognitive Assessment and Training Market - Global Forecast to 2021"The major forces driving this market are aging global population, increasing awareness about brain fitness, and advancements in technology.
The growing market for cognitive solutions and increasing demand for brain training by next-generation tech-savvy population are contributing to the growth of the cognitive assessment and training market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1039Clinical trials in terms of application is expected to hold the largest market share in the cognitive assessment and training market during the forecast periodClinical trials are mainly used to identify, measure, or monitor cognitive impairments and cognitive changes.
The assessment of cognitive functions is an integral part of decision-making during clinical drug development, as certain drugs can have an impact on the cognitive capabilities of the brain.
The market is expected to contribute the highest revenue for vendors offering clinical trials.Education vertical is expected to grow at the highest CAGR in the marketCognitive assessment solutions and services are used in the education vertical for screening prospective candidates for schools or colleges.
The leading cognitive assessment and training vendors for this vertical are Pearson Assessment and CogniFit.North America is expected to contribute to the largest market share and Asia-Pacific to grow at the highest CAGRNorth America is expected to hold the largest market share and to dominate the cognitive assessment and training market from 2016 to 2021, due to the increasing awareness among population about adopting medication for cognitive diseases.
The new generation in this region is more concerned toward the benefits of cognitive training, which is not just limited to patients with cognitive dysfunctions.